Patent details

Basic Information

Publication number:

EP2742356

PCT Application Number:

PCT/US/2012/049941

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127541241

PCT Publication Number:

WO/2013/022935

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREDICTORS FOR CANCER TREATMENT

French Title of Invention:

PRÉDICTEURS DE TRAITEMENT DU CANCER

German Title of Invention:

PRÄDIKTOREN FÜR KREBSBEHANDLUNG

SPC Number:

Dates

Filing date:

08/08/2012

Grant date:

27/04/2016

EP Publication Date:

27/04/2016

PCT Publication Date:

14/02/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/06/2014

EP B1 Publication Date:

27/04/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/08/2021

Expiration date:

08/08/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/08/2012

 

 

Name:

Janssen Pharmaceutica N.V.

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

08/06/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

HENITZ Erin, Devay

Address:

United States (US)

2

Name:

RICCI Deborah

Address:

United States (US)

3

Name:

LI Weimin

Address:

United States (US)

Priority

1

Priority Number:

201161522596

Priority Date:

11/08/2011

Priority Country:

United States (US)

2

Priority Number:

201161560555

Priority Date:

16/11/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

G01N 33/574;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/07/2020

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages